Biostax Corp.
BTAX
$0.0002
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -57.01% | 15.91% | 22.55% | 5.22% | -44.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -68.12% | -31.43% | -33.97% | 9.07% | -16.30% |
| Operating Income | 68.12% | 31.43% | 33.97% | -9.07% | 16.30% |
| Income Before Tax | 90.69% | 15.11% | 18.99% | -277.73% | 84.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 90.69% | 15.11% | 18.99% | -277.73% | 84.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 90.69% | 15.11% | 18.99% | -277.73% | 84.41% |
| EBIT | 68.12% | 31.43% | 33.97% | -9.07% | 16.30% |
| EBITDA | 70.81% | 32.45% | 35.17% | -- | -- |
| EPS Basic | 91.49% | 16.39% | 20.00% | -270.59% | 88.67% |
| Normalized Basic EPS | 89.66% | 15.79% | 19.35% | -33.33% | 35.56% |
| EPS Diluted | 91.49% | 0.00% | 20.00% | -223.08% | 88.67% |
| Normalized Diluted EPS | 89.66% | 15.79% | 19.35% | -33.33% | 35.56% |
| Average Basic Shares Outstanding | 0.64% | 0.50% | 0.56% | 0.51% | 38.53% |
| Average Diluted Shares Outstanding | 0.64% | 0.50% | 3.05% | 0.51% | 38.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |